“[W]ith the announcement of the Dallas case, hospitals across the country are now scrambling to get their procedures in place. Doctors’ offices should do so, too. They need to download the CDC’s checklists. And they need to do what other high-risk professions have done for years and train people immediately in ‘closed-loop communication’ —confirming verbally that critical information has been received and understood.”
— Atul Gawande, MD, surgeon and staff writer for The New Yorker
“The worst supply chain in our society is the health information supply chain. It’s just a wonderfully poignant example, [a] reminder of how disconnected our healthcare system is. … The hyperbole should not be directed at Epic or those guys at Health Texas. The hyperbole has to be directed at the fact that healthcare is islands of information trying to separately manage a massively complex network.”
— Jonathan Bush, head of Athenahealth, regarding initial reports that a flaw in the EHR system at Texas Health Presbyterian contributed to the hospital’s release of Thomas Eric Duncan when he first visited the hospital Sept. 25
“There are people out there who think that you can build a wall around an epidemic in the age of globalization and you can use the sorts of tactics to stop Ebola that we would be applied to plagues in the 18th century. Screen them at the port, don’t let them on the ship, then screen them before they get off the ship. … It doesn’t take two weeks to get from point A to point B anymore. It takes hours.”
— Laurie Garrett, senior fellow for global health at the Council of Foreign Relations
“The U.S. dropped the ball on advancing a number of promising Ebola drugs and vaccines over the last decade. Medical countermeasures floundered for years in preclinical testing, largely because funding was sparse, and regulators applied conservative terms to how they wanted these medical products to be tested. In short, there was no sense of urgency.”
— Scott Gottlieb, MD, resident fellow at the American Enterprise Institute and former deputy commissioner of the Food and Drug Administration, and Tevi Troy, former deputy secretary of HHS and president of the American Health Policy Institute, in an op-ed for the Wall Street Journal